Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and June 2017

Showing 1 to 10 of 133
Title Reference number Published Last updated
Preventing recurrence of Clostridium difficile infection: bezlotoxumab Reference number:ES13 ES00013 Published:June 2017 20170601 Last updated:June 2017 20170606
Non-cystic fibrosis bronchiectasis: inhaled tobramycin Reference number:ES12 ES00012 Published:April 2017 20170401 Last updated:April 2017 20170404
Mitochondrial disorders in children: Co-enzyme Q10 Reference number:ES11 ES00011 Published:March 2017 20170301 Last updated:March 2017 20170328
Hyperhidrosis: oxybutynin Reference number:ES10 ES00010 Published:March 2017 20170301 Last updated:March 2017 20170321
Parkinson’s disease with end-of-dose motor fluctuations: opicapone Reference number:ES9 ES00009 Published:March 2017 20170301 Last updated:March 2017 20170321
Narcolepsy with or without cataplexy in adults: pitolisant Reference number:ES8 ES00008 Published:March 2017 20170301 Last updated:March 2017 20170314
Skin involvement in systemic sclerosis: rituximab Reference number:ES7 ES00007 Published:March 2017 20170301 Last updated:March 2017 20170307
Parkinson’s disease with motor fluctuations: safinamide Reference number:ES6 ES00006 Published:February 2017 20170201 Last updated:February 2017 20170221
Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide Reference number:ES5 ES00005 Published:February 2017 20170201 Last updated:February 2017 20170214
Refractory extrapulmonary sarcoidosis: infliximab Reference number:ES4 ES00004 Published:January 2017 20170101 Last updated:January 2017 20170117